Clinical Trials Directory

Trials / Completed

CompletedNCT04443946

Different Anesthesia Maintain Protocol Effect the Outcome of the Patients

Different Anesthesia Maintain Protocol Effect the Outcome of the Patients Undergoing General Anesthesia for Urinary Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
China International Neuroscience Institution · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This prospective open-label randomized study, patients were having elective urological surgery scheduled to last longer than 1 h under necessitating general anesthesia.Group-P: (Propofol group): 3 mg kg-1 min-1 propofol was pumped continuously after endotracheal intubation. Group-PAS: (Propofol and after 20 min adding Sevoflurane group): 3 mg kg-1 min-1 propofol were pumped continuously and add 1% end-tidal sevoflurane 20 minutes after endotracheal intubation. Group-PS: (Propofol and Sevoflurane group): 3 mg kg-1 min-1 propofol were continuously pumped after endotracheal intubation, and 1% sevoflurane was inhaled continuously at the same time. Group-S: (Sevoflurane group): 1% sevoflurane continued to maintain anesthesia after endotracheal intubation. Group-PSu: (Propofol and Sufentanil group): 3 mg kg-1 min-1 propofol, 0.01 μ g kg-1 min-1 sufentanil were pumped continuously at maintain phase

Detailed description

Group-P: (Propofol group): 3 mg kg-1 min-1 propofol was pumped continuously after endotracheal intubation. Group-PAS: (Propofol and after 20 min adding Sevoflurane group): 3 mg kg-1 min-1 propofol were pumped continuously and add 1% end-tidal sevoflurane 20 minutes after endotracheal intubation. Group-PS: (Propofol and Sevoflurane group): 3 mg kg-1 min-1 propofol were continuously pumped after endotracheal intubation, and 1% sevoflurane was inhaled continuously at the same time. Group-S: (Sevoflurane group): 1% sevoflurane continued to maintain anesthesia after endotracheal intubation. Group-PSu: (Propofol and Sufentanil group): 3 mg kg-1 min-1 propofol, 0.01 μ g kg-1 min-1 sufentanil were pumped continuously at maintain phase. Due to the ethical requirements of adequent analgesia, 0.3 μ g kg-1 min-1 remifentanil was continuously pumped as background input dose during anesthesia maintenance in all groups.

Conditions

Interventions

TypeNameDescription
DRUGPropofol5 mg kg-1 h-1 propofol was pumped continuously after endotracheal intubation.
DRUG1% Sevofluraneadd 1% end-tidal sevoflurane 20 minutes after endotracheal intubation.
DRUG1% Sevoflurane continue1% sevoflurane continued to maintain anesthesia after endotracheal intubation.
DRUGSufentanil0.01 μ g kg-1 min-1 sufentanil were pumped continuously at maintain phase
DRUG2% Sevoflurane2% sevoflurane continued to maintain anesthesia after endotracheal intubation.
DRUGPropofol half2.5 mg kg-1 h-1 propofol was pumped continuously after endotracheal intubation.

Timeline

Start date
2020-06-25
Primary completion
2020-08-05
Completion
2020-08-05
First posted
2020-06-23
Last updated
2020-10-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04443946. Inclusion in this directory is not an endorsement.

Different Anesthesia Maintain Protocol Effect the Outcome of the Patients (NCT04443946) · Clinical Trials Directory